Skip to content
StockMarketAgent
Healthcare / Medical Instruments & SuppliesUpdated 2026-05-10 22:07 UTC

IDX/OMED stock hub

IDX/OMED has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

IDX/OMEDis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
8T
Indonesia Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
IDX/OMED
In the news

Latest news · IDX/OMED

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E21
P25 9.4P50 14.4P75 23.9
Trailing P/E20.5
P25 11.5P50 23.8P75 52.6
ROE14.6
P25 0.6P50 5.1P75 12.2
ROIC20.8
P25 1.3P50 6P75 11.8
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All IDX/OMED market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
216
Groups with data
11
Currency
IDR
Showing 216 of 216 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
Indonesia
Country code
ID
Employees
1,350
Employees Change
152%
Employees Change Percent
12.69
Enterprise value
IDR 7T
Exchange
Indonesia Stock Exchange
Financial currency
IDR
First seen
2026-05-10
Industry
Medical Instruments & Supplies
Isin
ID1000176209
Last refreshed
2026-05-10
Market cap
IDR 8T
Price
IDR 298
Price currency
IDR
Rev Per Employee
1,629,444,238.43x
Sector
Healthcare
Sic
3842
Symbol
idx/OMED
Website
https://www.onemed.co.id

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

13
MetricValue
Earnings Yield
4.88%
EV Earnings
17.78x
EV/EBIT
16.05x
EV/EBITDA
13.71x
EV/FCF
30.99x
EV/Sales
3.17x
FCF yield
2.8%
Forward P/E
20.99x
P/B ratio
2.82x
P/E ratio
20.52x
P/S ratio
3.66x
PE Ratio3 Y
17.11x
PE Ratio5 Y
17.58x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

25
MetricValue
EBIT Margin
19.77%
EBITDA Margin
22.31%
FCF margin
10.24%
Gross margin
35.49%
Gross Profit
IDR 780.7B
Gross Profit Growth
24.49%
Gross Profit Growth Q
44.56%
Gross Profit Growth3 Y
13.36%
Net Income
IDR 392.6B
Net Income Growth
18.61%
Net Income Growth Q
35.19%
Net Income Growth Quarters
5%
Net Income Growth Years
2%
Net Income Growth3 Y
14.8%
Pretax Margin
22.23%
Profit Margin
17.85%
Profit Per Employee
IDR 290.8M
Profitable Years
7
ROA
8.69
Roa5y
12.72
ROCE
14.05
ROE
14.57
Roe5y
21.86
ROIC
20.79
Roic5y
43.18

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

16
MetricValue
Cagr1y
90.28%
Cagr3y
16.8%
EPS Growth
18.74
EPS Growth Q
35.44
EPS Growth Quarters
5
EPS Growth Years
2
EPS Growth3 Y
16.26
FCF Growth
-30.36%
FCF Growth Q
-66.77%
OCF Growth
-19.09%
OCF Growth Q
-58.18%
Revenue Growth
16.1x
Revenue Growth Q
31.16x
Revenue Growth Quarters
8x
Revenue Growth Years
2x
Revenue Growth3 Y
9.27x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

23
MetricValue
Asset Turnover
IDR 0.7
Assets
IDR 3.3T
Cash
IDR 1.4T
Current Assets
IDR 2.5T
Current Liabilities
IDR 225.4B
Debt
IDR 267.5B
Debt EBITDA
IDR 0.53
Debt Equity
IDR 0.09
Debt FCF
IDR 1.19
Equity
IDR 2.9T
Interest Coverage
24.41
Liabilities
IDR 470.2B
Long Term Assets
IDR 824.1B
Long Term Liabilities
IDR 244.7B
Net Cash
IDR 1.1T
Net Cash By Market Cap
IDR 13.66
Net Cash Growth
-6.7%
Net Debt EBITDA
IDR -2.24
Net Debt Equity
IDR -0.39
Net Debt FCF
IDR -4.88
Tangible Book Value
IDR 2.8T
Tangible Book Value Per Share
IDR 104
WACC
5.54

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
11.08
Inventory Turnover
1.91
Net Working Capital
IDR 955B
Quick ratio
7.41
Working Capital
IDR 2.3T
Working Capital Turnover
IDR 1.03

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

8
MetricValue
Buyback Yield
0.11%
Dividend Growth
23.96%
Dividend Growth Years
1%
Dividend per share
IDR 3.57
Dividend Years
3
Dividend Yield
1.2%
Last Dividend
IDR 3.57
Payout Ratio
24.6%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

36
MetricValue
1Y total return
90.2%
200-day SMA
214.9
3Y total return
59.35%
50-day SMA
264.4
50-day SMA vs 200-day SMA
50over200
All Time High
318
All Time High Change
-6.29%
All Time High Date
2026-04-16
All Time Low
143
All Time Low Change
108.39%
All Time Low Date
2025-03-03
ATR
17.68
Beta
0.24
Beta1y
0.32
Beta2y
0.36
Ch YTD
44.66
High
310
High52
318
High52 Date
2026-04-16
High52ch
-6.29%
Low
282
Low52
159
Low52 Date
2025-05-08
Low52ch
88.61%
Ma50ch
12.71%
Price vs 200-day SMA
38.68%
RSI
60.24
RSI Monthly
79.4
RSI Weekly
79.62
Sharpe ratio
1.96x
Sortino ratio
3.65
Total Return
1.31%
Tr YTD
44.66
Tr1m
14.62%
Tr1w
7.19%
Tr3m
43.27%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

5
MetricValue
Operating Income
IDR 435B
Operating Income Growth
29.97
Operating Income Growth Q
67.76
Operating Income Growth3 Y
9.27
Operating margin
19.77

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

6
MetricValue
Float
3,970,061,100%
Net Borrowing
64,624,773,339
Shares Insiders
1.84%
Shares Out
27,008,119,900
Shares Qo Q
-0.04%
Shares Yo Y
-0.11%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

58
MetricValue
Adjusted FCF
IDR 225.3B
Average Volume
28,769,985x
Bv Per Share
104.4
CAPEX
IDR -109.6B
Ch1m
14.62
Ch1w
7.19
Ch1y
86.25
Ch3m
43.27
Ch3y
51.27
Ch6m
51.27
Change
5.67%
Change From Open
4.93
Close
282
Days Gap
0.71
Depreciation Amortization
55,741,606,209
Dollar Volume
18,517,034,600
Earnings Date
2026-07-29
EBIT
IDR 435B
EBITDA
IDR 490.7B
EPS
IDR 14.52
F Score
6
FCF
IDR 225.3B
FCF EV Yield
3.23x
FCF Per Share
IDR 8.34
Financing CF
-45,369,793,950
Fiscal Year End
December
Founded
2,000
Graham Number
184.67991
Graham Upside
-38.03
Income Tax
IDR 94.2B
Investing CF
-245,389,036,096
Is Primary Listing
1
Last Earnings Date
2025-10-29
Last Report Date
2026-03-31
Lynch Fair Value
IDR 215
Lynch Upside
-27.86
Ma150
225.2
Ma150ch
32.34%
Ma20
292.4
Ma20ch
1.92%
Net CF
22,798,430,017
Next Earnings Date
2026-07-29
Open
284
P FCF Ratio
35.73
P OCF Ratio
24.03
Payment Date
2025-07-25
Position In Range
57.14
Ppne
540,300,561,359
Price Date
2026-05-08
Price EBITDA
IDR 16.4
Ptbv Ratio
2.86
Relative Volume
2.33x
Revenue
2,199,749,721,880x
Tax By Revenue
4.28x
Tax Rate
19.27%
Tr6m
51.27%
Volume
62,137,700
Z Score
9.47
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

IDX/OMED dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield
+1.2%
$3.57 annual per share
Payout ratio
+24.6%
Share of earnings returned as dividends. Below 60% is generally sustainable.
5Y dividend CAGR
n/a
1 consecutive years of growth
Total shareholder yield
+1.3%
Dividend yield + buyback yield combined
Performance

IDX/OMED stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+90.2%
S&P 500 1Y: n/a
3Y total return
+59.4%
S&P 500 3Y: n/a
5Y total return
n/a
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns IDX/OMED?

Insider, institutional, and short-interest positioning.

Institutional ownership
n/a
Share of float held by funds and institutions
Insider ownership
+1.8%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
-0.1%
Negative means the company is buying back shares.
Technical

IDX/OMED momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
60.2
Neutral momentum band
Price vs 200-day MA
+38.7%
50/200-day relationship not available
Beta (5Y)
0.24
Less volatile than the market
Sharpe ratio
1.96
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About IDX/OMED

Hub-level FAQ points readers to the deeper analysis pages.

What is the current idx/OMED stock rating?

idx/OMED is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full idx/OMED analysis?

The full report lives at /stocks/idx/OMED/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for idx/OMED?

The latest report frames idx/OMED around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the idx/OMED page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.

idx/OMED stock profile: metrics, valuation and analysis | Agente AI del Mercato Azionario